Illumina Inc. Equity-NMS: ILMN

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$227.44

52W high :

$526

1Y :

-59.76%

5Y :

8.06%

EPS(TTM): :

4.55

Shares O/S :

157.1 M

Market cap :

32.73 B

What is the share price of Illumina Inc. today?

Illumina Inc. (ILMN) share price as of August 12, 2022, is $208.33. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Illumina Inc.?

Yes, Indian Investors can invest in the Illumina Inc. (ILMN) Share by opening an international trading account with Angel One.

How can I purchase Illumina Inc. shares in India?

Purchasing Illumina Inc. (ILMN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Illumina Inc. (ILMN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Illumina Inc.?

Yes, you can purchase fractional shares of Illumina Inc. (ILMN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Illumina Inc.?

The market capitalization of Illumina Inc. on August 14, 2022, is $32.73 B.

In which sector Illumina Inc. belongs?

Illumina Inc. operates in the Healthcare sector, specifically in the Diagnostics & Research industry.

What documents are required to invest in Illumina Inc. stocks?

In order to invest in Illumina Inc. (ILMN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.